{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:22:27Z","timestamp":1792606947714,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jaci.2021.11.012","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T10:51:18Z","timestamp":1637837478000},"page":"517-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["2021 year in review: Spotlight on eosinophils"],"prefix":"10.1016","volume":"149","author":[{"given":"Julia L.M.","family":"Dunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.11.012_bib1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaci.2019.12.009","article-title":"Severe asthma in the US population and eligibility for mAb therapy","volume":"145","author":"Akenroye","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jaci.2020.08.037","article-title":"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial","volume":"146","author":"Roufosse","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib3","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/all.14266","article-title":"Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma","volume":"75","author":"Howarth","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.11.012_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaci.2020.05.054","article-title":"Eosinophil paradox with mepolizumab in chronic rhinosinusitis with nasal polyposis","volume":"146","author":"Lipworth","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaci.2021.02.009","article-title":"Benralizumab for adolescent patients with severe, eosinophilic asthma: safety and efficacy after 3 years of treatment","volume":"148","author":"Busse","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jaci.2020.08.004","article-title":"Identification of whole blood gene expressions correlated with responsiveness to benralizumab","volume":"147","author":"Nakajima","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2021.05.043","article-title":"Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease","volume":"148","author":"Buchheit","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaci.2019.11.012","article-title":"Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)","volume":"145","author":"Aceves","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.giec.2007.09.016","article-title":"Basic pathogenesis of eosinophilic esophagitis","volume":"18","author":"Blanchard","year":"2008","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.jaci.2021.11.012_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","article-title":"Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: multi-site study","volume":"145","author":"Shoda","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2019.11.011","article-title":"Diagnosis and treatment of eosinophilic esophagitis","volume":"145","author":"Gonsalves","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaci.2019.10.013","article-title":"Eosinophilic gastrointestinal disease below the belt","volume":"145","author":"Pesek","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaci.2020.04.062","article-title":"Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers","volume":"147","author":"Bakker","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib14","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1016\/j.jaip.2021.06.030","article-title":"Unsedated transnasal esophagoscopy with virtual reality distraction enables earlier monitoring of dietary therapy in eosinophilic esophagitis","volume":"9","author":"Friedlander","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.11.012_bib15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mi.2015.2","article-title":"Eosinophils in mucosal immune responses","volume":"8","author":"Travers","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib16","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2020.01.051","article-title":"Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort","volume":"145","author":"Dunn","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(18)30096-7","article-title":"Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study","volume":"3","author":"Shoda","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2021.11.012_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaci.2020.05.045","article-title":"Eosinophilic esophagitis with extremely high esophageal eosinophil counts","volume":"147","author":"O\u2019Shea","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi5586","article-title":"Clonally expanded, GPR15-expressing pathogenic effector TH2 cells are associated with eosinophilic esophagitis","volume":"6","author":"Morgan","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaci.2019.07.049","article-title":"Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis","volume":"145","author":"Vanoni","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaci.2020.03.045","article-title":"An anti\u2013IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: phase 2 trial results","volume":"146","author":"Gann","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.11.012_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cgh.2020.03.036","article-title":"Long-term efficacy and tolerability of RPC4046 in an open-label extension trial of patients with eosinophilic esophagitis","volume":"19","author":"Dellon","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2021.11.012_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.11.012_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1146\/annurev-immunol-093019-125918","article-title":"Eosinophil knockout humans: uncovering the role of eosinophils through eosinophil-directed biological therapies","volume":"39","author":"Jacobsen","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib25","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.012_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126219","article-title":"Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis","volume":"4","author":"Youngblood","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2021.11.012_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000501637","article-title":"AK002, a humanized Sialic acid-binding immunoglobulin-like lectin-8 antibody that induces antibody-dependent cell-mediated cytotoxicity against human eosinophils and inhibits mast cell-mediated anaphylaxis in mice","volume":"180","author":"Youngblood","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaci.2011.05.006","article-title":"Long-term outcomes in pediatric-onset esophageal eosinophilia","volume":"128","author":"DeBrosse","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaci.2010.05.027","article-title":"Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999","volume":"126","author":"DeBrosse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9736","article-title":"The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses","volume":"10","author":"Azouz","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2021.11.012_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaci.2019.11.005","article-title":"Relationship of skin barrier breakdown and eosinophilic esophagitis","volume":"145","author":"Simon","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz7773","article-title":"Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis","volume":"12","author":"Azouz","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2021.11.012_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2008.01.004","article-title":"Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases","volume":"6","author":"Collins","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2021.11.012_bib35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2014.07.021","article-title":"Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis","volume":"134","author":"Alexander","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jaci.2020.10.017","article-title":"Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants","volume":"147","author":"Lyles","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: proceedings of the AGREE Conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.11.012_bib39","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jaci.2020.09.039","article-title":"Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors","volume":"147","author":"Rochman","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2019.09.028","article-title":"Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes","volume":"145","author":"Levy","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib41","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaci.2020.02.032","article-title":"Omeprazole inhibits IgE-mediated mast cell activation and allergic inflammation induced by ingested allergen in mice","volume":"146","author":"Kanagaratham","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib42","doi-asserted-by":"crossref","first-page":"984","DOI":"10.14309\/ajg.0000000000000228","article-title":"Increasing rates of diagnosis, substantial co-occurrence, and variable treatment patterns of eosinophilic gastritis, gastroenteritis, and colitis based on 10-year data across a multicenter consortium","volume":"114","author":"Pesek","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2021.11.012_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2020.04.021","article-title":"Eosinophil responses during COVID-19 infections and coronavirus vaccination","volume":"146","author":"Lindsley","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1159\/000509368","article-title":"Strategies to prevent SARS-CoV-2-mediated eosinophilic disease in association with COVID-19 vaccination and infection","volume":"181","author":"Simon","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.650331","article-title":"Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-Siglec-8 antibody","volume":"12","author":"Gebremeskel","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaci.2020.05.003","article-title":"Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China","volume":"146","author":"Chen","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib47","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaip.2020.12.045","article-title":"Eosinophilia in asthma patients is protective against severe COVID-19 illness","volume":"9","author":"Ferastraoaru","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.11.012_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaci.2020.09.026","article-title":"Eosinophilic pulmonary vasculitis as a manifestation of the hyperinflammatory phase of COVID-19","volume":"147","author":"Luecke","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2020.05.051","article-title":"Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype","volume":"146","author":"Camiolo","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib50","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jaci.2020.07.026","article-title":"Asthma among hospitalized patients with COVID-19 and related outcomes","volume":"146","author":"Lovinsky-Desir","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaci.2020.05.004","article-title":"Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells","volume":"146","author":"Kimura","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib52","doi-asserted-by":"crossref","unstructured":"Qeadan F, Chehade M, Tingey B, Egbert J, Dellon ES, Peterson KA. Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19 [published online ahead of print September 23, 2021]. J Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2021.09.022","DOI":"10.1016\/j.jaip.2021.09.022"},{"key":"10.1016\/j.jaci.2021.11.012_bib53","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/MPG.0000000000003032","article-title":"Type 2 immunity and age modify gene expression of coronavirus-induced disease 2019 receptors in eosinophilic gastrointestinal disorders","volume":"72","author":"Chiang","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2021.11.012_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaci.2019.10.027","article-title":"Emerging therapies for eosinophilic esophagitis","volume":"145","author":"Greuter","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2020.01.020","article-title":"Biologics for chronic rhinosinusitis with nasal polyps","volume":"145","author":"Bachert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3838","article-title":"Targeting eosinophils in allergy, inflammation and beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2021.11.012_bib57","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jaci.2020.12.002","article-title":"A tribute to eosinophils from a comparative and evolutionary perspective","volume":"147","author":"Stacy","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib58","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jaci.2020.02.002","article-title":"Severe eosinophilic asthma with nasal polyposis: a phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy","volume":"145","author":"Howarth","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib59","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jaip.2020.01.009","article-title":"Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps","volume":"8","author":"Chan","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.11.012_bib60","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaci.2020.01.035","article-title":"Understanding the asthmatic response to an experimental rhinovirus infection: exploring the effects of blocking IgE","volume":"146","author":"Heymann","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib61","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jaci.2021.03.016","article-title":"What is the contribution of IgE to nasal polyposis?","volume":"147","author":"Bachert","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.imbio.2016.09.006","article-title":"Regulation of Siglec-8-induced intracellular reactive oxygen species production and eosinophil cell death by Src family kinases","volume":"222","author":"Kano","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2021.11.012_bib64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000488951","article-title":"Characterization of Siglec-8 expression on lavage cells after segmental lung allergen challenge","volume":"177","author":"Johansson","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib65","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.jaci.2018.10.066","article-title":"Sialic acid\u2013binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: receptor expression and targeting using chimeric antibodies","volume":"143","author":"Legrand","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib66","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jaci.2020.12.623","article-title":"Defective STING expression potentiates IL-13 signaling in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib67","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2019.10.031","article-title":"An endothelial microRNA-1\u2013regulated network controls eosinophil trafficking in asthma and chronic rhinosinusitis","volume":"145","author":"Korde","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib68","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jaci.2020.01.022","article-title":"\u03b1IIb-Integrin (CD41) associated with blood eosinophils is a potential biomarker for disease activity in eosinophilic esophagitis","volume":"145","author":"Johansson","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib69","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jaci.2019.12.893","article-title":"Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis","volume":"145","author":"Tsuda","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib70","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaip.2019.08.025","article-title":"Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity, and poor response to treatment","volume":"8","author":"Kolkhir","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.11.012_bib71","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jaci.2020.03.005","article-title":"The role of eosinophils in chronic spontaneous urticaria","volume":"145","author":"Altrichter","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib72","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMc2016395","article-title":"Benralizumab for chronic spontaneous urticaria","volume":"383","author":"Bernstein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.012_bib73","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaci.2019.09.030","article-title":"Severe asthma during childhood and adolescence: a longitudinal study","volume":"145","author":"Ross","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib74","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaci.2019.08.031","article-title":"Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma","volume":"145","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib75","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jaci.2020.01.021","article-title":"Serum IL-6: a biomarker in childhood asthma?","volume":"145","author":"Jackson","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib76","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaci.2020.01.039","article-title":"Baseline sputum eosinophil\u00a0+ neutrophil subgroups\u2019 clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) cohort","volume":"146","author":"Hastie","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib77","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2019.12.002","article-title":"Expert-level diagnosis of nasal polyps using deep learning on whole-slide imaging","volume":"145","author":"Wu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib78","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2019.07.009","article-title":"The IL-37\u2013Mex3B\u2013Toll-like receptor 3 axis in epithelial cells in patients with eosinophilic chronic rhinosinusitis with nasal polyps","volume":"145","author":"Liu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib79","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jaci.2020.11.037","article-title":"Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps","volume":"147","author":"Klingler","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2020.04.040","article-title":"Type 2 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype","volume":"146","author":"Delemarre","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib81","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaci.2020.01.027","article-title":"Formation of nasal polyps: the roles of innate type 2 inflammation and deposition of fibrin","volume":"145","author":"Takabayashi","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib82","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2020.08.027","article-title":"Mas-related G protein\u2013coupled receptor X2 and its activators in dermatologic allergies","volume":"147","author":"K\u00fchn","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib83","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jaci.2020.04.005","article-title":"Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome","volume":"146","author":"Rigoni","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib84","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaci.2021.01.013","article-title":"Biomarkers in atopic dermatitis\u2014a review on behalf of the International Eczema Council","volume":"147","author":"Renert-Yuval","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib85","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaci.2020.05.037","article-title":"TH cell diversity and response to dupilumab in patients with atopic dermatitis","volume":"147","author":"Trichot","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib86","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2021.01.033","article-title":"Sputum mast cell\/basophil gene expression relates to inflammatory and clinical features of severe asthma","volume":"148","author":"Winter","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2020.08.036","article-title":"A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps","volume":"147","author":"Delemarre","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib88","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jaci.2021.01.002","article-title":"miR103a-3p in extracellular vesicles from Fc\u03b5RI-aggregated human mast cells enhances IL-5 production by group 2 innate lymphoid cells","volume":"147","author":"Toyoshima","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib89","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaci.2020.04.032","article-title":"Active control of mucosal tolerance and inflammation by human IgA and IgG antibodies","volume":"146","author":"Hoepel","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib90","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41385-021-00416-4","article-title":"Aiolos regulates eosinophil migration into tissues","volume":"14","author":"Felton","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib37","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s41385-021-00400-y","article-title":"Bidirectional crosstalk between eosinophils and esophageal epithelial cells regulates inflammatory and remodeling processes","volume":"14","author":"Dunn","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib91","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4049\/jimmunol.2000207","article-title":"Epigenetic analysis of the chromatin landscape identifies a repertoire of murine eosinophil-specific PU.1-bound enhancers","volume":"207","author":"Felton","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaci.2019.11.013","article-title":"The genetic etiology of eosinophilic esophagitis","volume":"145","author":"Kottyan","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib93","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1172\/JCI125917","article-title":"Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis","volume":"130","author":"Wen","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2021.11.012_bib94","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaci.2020.09.032","article-title":"Single-cell transcriptomic analysis reveals key immune cell phenotypes in the lungs of patients with asthma exacerbation","volume":"147","author":"Li","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib95","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaci.2020.01.013","article-title":"Charcot-Leyden crystal protein\/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis","volume":"146","author":"Grozdanovic","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coi.2021.03.013","article-title":"Charcot-Leyden crystals and other protein crystals driving type 2 immunity and allergy","volume":"72","author":"Aegerter","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib97","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1109\/OJEMB.2021.3089552","article-title":"Machine learning approach for biopsy-based identification of eosinophilic esophagitis reveals importance of global features","volume":"2","author":"Czyzewski","year":"2021","journal-title":"IEEE Open J Eng Med Biol"},{"key":"10.1016\/j.jaci.2021.11.012_bib98","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2021.01.023","article-title":"A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis","volume":"148","author":"Hsieh","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib99","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaci.2020.06.037","article-title":"Proteomic analysis of nasal mucus samples of healthy patients and patients with chronic rhinosinusitis","volume":"147","author":"Kao","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib100","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jaci.2020.08.001","article-title":"Isolation, identification, and characterization of the human airway ligand for the eosinophil and mast cell immunoinhibitory receptor Siglec-8","volume":"147","author":"Gonzalez-Gil","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib101","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2020.10.018","article-title":"Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes","volume":"147","author":"Kottyan","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.012_bib102","doi-asserted-by":"crossref","unstructured":"Chang X, March M, Mentch F, Nguyen K, Glessner J, Qu H, et\u00a0al. A\u00a0genome-wide association meta-analysis identifies new eosinophilic esophagitis loci [published online ahead of print September 25, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.018.","DOI":"10.1016\/j.jaci.2021.08.018"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921017966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921017966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:35:50Z","timestamp":1758792950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921017966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0091674921017966"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.012","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2021 year in review: Spotlight on eosinophils","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}